26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cutaneous Immunization Rapidly Activates Liver Invariant Vα14 NKT Cells Stimulating B-1 B Cells to Initiate T Cell Recruitment for Elicitation of Contact Sensitivity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          T cell recruitment to elicit contact sensitivity (CS) requires a CS-initiating process mediated by B-1 cells that produce IgM, which activates complement to promote T cell passage into the tissues. We now show that Vα14i NKT cells induce B-1 cell activation likely by releasing IL-4 early postimmunization. The CS initiation process is absent in Jα18 −/− and CD1d −/− NKT cell–deficient mice and is reconstituted by populations enriched for Vα14i NKT cells. Transfers are not effective if cells are derived from IL-4 −/− mice. Staining with specific tetramers directly showed that hepatic Vα14i NKT cells increase by 30 min and nearly double by 2 h postimmunization. Transfer of immune B-1 cells also reconstitutes CS responses in NKT cell–deficient mice. The B-1 cells act downstream of the Vα14i NKT cells to restore CS initiation. In addition, IL-4 given systemically to Jα18 −/− or CD1d −/− NKT cell–deficient mice reconstitutes elicitation of CS. Further, splenocytes from immune Jα18 −/− mice produce less antigen (Ag)-specific IgM antibodies compared with sensitized WT mice. Together these findings indicate that very early after skin immunization Vα14i NKT cells are stimulated to produce IL-4, which activates B-1 cells to produce Ag-specific IgM, subsequently needed to recruit effector T cells for elicitation of CS responses.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

          Natural killer T (NKT) lymphocytes express an invariant T cell antigen receptor (TCR) encoded by the Valpha14 and Jalpha281 gene segments. A glycosylceramide-containing alpha-anomeric sugar with a longer fatty acyl chain (C26) and sphingosine base (C18) was identified as a ligand for this TCR. Glycosylceramide-mediated proliferative responses of Valpha14 NKT cells were abrogated by treatment with chloroquine-concanamycin A or by monoclonal antibodies against CD1d/Vbeta8, CD40/CD40L, or B7/CTLA-4/CD28, but not by interference with the function of a transporter-associated protein. Thus, this lymphocyte shares distinct recognition systems with either T or NK cells.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Lymphocyte responses and cytokines.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.

              Experimental autoimmune encephalomyelitis (EAE) is a prototype autoimmune disease mediated by type 1 helper T (TH1) cells and under the control of regulatory cells. Here we report that a synthetic glycolipid ligand for CD1d-restricted natural killer T (NKT) cells expressing the semi-invariant T-cell receptor (Valpha14+) is preventive against EAE. The ligand is an analogue of alpha-galactosylceramide (alpha-GC), a prototype NKT cell ligand, with a truncated sphingosine chain. alpha-GC causes NKT cells to produce both interferon (IFN)-gamma and interleukin (IL)-4 (refs 4, 5). However, this new ligand can induce a predominant production of IL-4 by the NKT cells. A single injection of this glycolipid, but not of alpha-GC, consistently induced TH2 bias of autoimmune T cells by causing NKT cells to produce IL-4, leading to suppression of EAE. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                15 December 2003
                : 198
                : 12
                : 1785-1796
                Affiliations
                [1 ]Section of Allergy and Clinical Immunology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520
                [2 ]Department of Human Developmental Biology, Jagiellonian University College of Medicine, 31-008 Krakow, Poland
                [3 ]Laboratório de Alergia e Imunologia Clínica e Experimental (LIM-56), Faculdade de Medicina da Universidade de São Paulo, 01246-000 São Paulo, Brasil
                [4 ]La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
                Author notes

                Address correspondence to Philip W. Askenase, Section of Allergy and Clinical Immunology, Dept. of Medicine, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520-8013. Phone: (203) 785-4143; Fax: (203) 785-3229; email: philip.askenase@ 123456yale.edu

                Article
                20021562
                10.1084/jem.20021562
                2194147
                14676294
                2df0c49b-d4fe-4c31-8f28-9b52b82b1fab
                Copyright © 2003, The Rockefeller University Press
                History
                : 5 September 2002
                : 20 August 2003
                Categories
                Article

                Medicine
                il-4,liver lymphocytes,b-1 cells,contact sensitivity,vα14i nkt cells
                Medicine
                il-4, liver lymphocytes, b-1 cells, contact sensitivity, vα14i nkt cells

                Comments

                Comment on this article